Effects of Food Cooking on Diabetes-2 Risk Factors (Age-2)

January 8, 2013 updated by: AAstrup, University of Copenhagen
The aim of the project is to investigate the effects of advanced glycation end products (AGEs) formed in food during the cooking process as well as AGEs formed naturally in the human body, on insulin sensitivity and risk factors for type 2 diabetes. The hypothesis is that i) food content of AGEs is lower using boiling and steaming cooking methods and that ii) AGEs formation in the body is lower at low dietary intake of certain sugar forms.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frederiksberg, Denmark
        • Department of Human Nutrition, University of Copenhagen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women, healthy between 20 and 50 y
  • BMI between 25 and 40 kg/m2
  • weight circumference over 88 cm

Exclusion Criteria:

  • weigh changes within the last 2 months more than +/- 3 kg
  • Physical activity more than 8 h per week
  • smoking
  • medications and supplements
  • being vegetarian or vegan
  • pregnancy or breast feeding
  • postmenopause
  • chronic disease
  • previous gastric bypass surgery
  • blood donation within the last 3 months
  • Involvement in other clinical trials
  • allergic to paraaminobenzoic acid

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: low AGE, glucose
Food prepared by boiling/steaming and 20 g of glucose 3 times a day in a water solution
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
Experimental: low AGE, fructose
Food prepared by boiling/steaming and 20 g of fructose 3 times a day in a water solution
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
Experimental: high AGE, fructose
Food prepared by frying/baking and 20 g of fructose 3 times a day in a water solution
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution
Experimental: high AGE, glucose
Food prepared by frying/baking and 20 g of glucose 3 times a day in a water solution
Food made by different cooking methods (boiling/steaming versus frying) and with glucose or fructose water solution

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in HOMA from baseline to 4 weeks
Time Frame: 0 and 4 weeks
insulin sensitivity
0 and 4 weeks
change in OGTT from baseline to 4 weeks
Time Frame: 0 and 4 weeks at 0 and 120 min
insulin sensitivity
0 and 4 weeks at 0 and 120 min
change in appetite hormones (leptin, adiponectin, GLP-1, glukagon, ghrelin) from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks
change in plasma and urin AGEs from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks
change in immune response (CRP, C-peptide, IL-1B, IL-6, VCAM, ICAM, MIF, TNF-a, buffycoat) from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks
change in metabolomics dats from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks
change in AGE levels in skin from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
change in lipid profile (TG, Chol, LDL, HDL, ox LDL, glycated LDL, fattyacids)from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks
change in HbA1c from baseline to 4 weeks
Time Frame: 0 and 4 weeks
0 and 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Susanne G Bügel, Department of Human Nutrition, University of Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

February 22, 2012

First Submitted That Met QC Criteria

June 7, 2012

First Posted (Estimate)

June 12, 2012

Study Record Updates

Last Update Posted (Estimate)

January 10, 2013

Last Update Submitted That Met QC Criteria

January 8, 2013

Last Verified

January 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Dietary intervention

Subscribe